Objective: To observe the effect of inhaled corticosteroid in patients with asthma.
前言：目的：观察吸入性激素治疗支气管哮喘病人的效果。
Background: Inhaled corticosteroid has played an important role in the management of asthma.
背景：吸入糖皮质激素治疗在哮喘治疗中具有重要作用。
Should longterm inhaled corticosteroid treatments be prescribed for mild persistent asthma?
轻度持续哮喘需要长期吸入激素治疗吗?。
Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy.
随机试验一次与吸入糖皮质激素治疗的哮喘儿童每日维兰特罗。
However, further studies are needed to determine the optimal dosing regimen for inhaled corticosteroid therapy for asthma.
但是需要进一步的研究来确定吸入性皮质类固醇治疗哮喘的最佳剂量。
Inhaled corticosteroid therapy after Ed discharge is associated with a significant reduction in the risk of subsequent Ed visits.
从急诊出院以后，接受吸入性皮质类固醇治疗与随后去急诊复诊的发生率明显降低有关。
Patients in the study were older than 18 years and had been given a prescription for an inhaled corticosteroid at some point during 2006.
研究中的患者年龄在18岁以上，并在2006年期间接受吸入性皮质类固醇制剂治疗。
Inclusion criteria were randomized controlled trials comparing any inhaled corticosteroid vs a control treatment of COPD, follow-up 24 weeks or longer, and reporting of pneumonia as an adverse event.
纳入标准是吸入糖皮质激素与COPD对照相比较的随机对照试验，持续24周或者更长，肺炎是治疗引起的副作用。
Inclusion criteria were randomized controlled trials comparing any inhaled corticosteroid vs a control treatment of COPD, follow-up 24 weeks or longer, and reporting of pneumonia as an adverse event.
纳入标准是吸入糖皮质激素与COPD对照相比较的随机对照试验，持续24周或者更长，肺炎是治疗引起的副作用。
应用推荐